Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Creative Bioarray

Located at Long Island, New York, Creative Bioarray was founded as biomedical company focused on providing comprehensive biotechnology and pharmaceutical array services and products for high-throughput analysis. Creative Bioarray uniquely pioneers the development of high quality tissue, antibody, protein and cell array technology to efficiently analyze the concurrent expression and function of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

Creative Bioarray
45-16 Ramsey Road Shirley, New York, NY 11967, United States
+1 631 624 4882
Contact Creative Bioarray
Website

 Latest Content from PMHub 

[CASE STUDIES] Delivering remote access to congress, symposia and enduring materials

White Papers and Resources | March 25, 2021 | EPG Health

See how three pharma companies supported the provision of virtual and on-demand scientific meetings for HCPs during COVID-19.

Integrated NHS finances: what do they mean for High Cost Drugs?

White Papers and Resources | March 24, 2021 | Wilmington Healthcare

Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs

Dovetail partners with Tillotts AG to map management of C. difficile infection in Europe

Press Releases | March 24, 2021 | Dovetail

Specialist stakeholder engagement consultancy Dovetail, based in London, UK, have announced a new partnership with Tillotts Pharma AG to support the launch of Tillotts’ recent acquisition DIFICLIR™ in the EU.

Taking steps to sustainability: Porterhouse celebrates achieving ISO 14001 certification

Press Releases | March 23, 2021 | Porterhouse Medical Group

Porterhouse Medical Group is proud to announce that we have passed the ISO (International Organization for Standardization) 14001 certification in environmental management.As part of our mission to improve lives, we...

Brain tumour awareness month: giving research a more humane face

Press Releases | March 23, 2021 | 11 London

Did you know that March is Brain Tumour Awareness Month? With brain tumour cases rising, funds are urgently needed to help find a cure for this swift, relentless killer.

There’s No Going Back: How COVID-19 will Change Pharma Forever

Videos and Podcasts | March 18, 2021 | Impetus Digital

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Leading Successful Change Through Innovative Digital Technologies

Videos and Podcasts | March 18, 2021 | Impetus Digital

Cassie Solomon, CEO of The New Group Consulting, dives into the future of innovation, digital technologies, and systems thinking in healthcare. Among many other things, we discuss how organizations can prepare...

Accession announces investment to support next phase of growth

Press Releases | March 18, 2021 | Accession

March 2021: Accession Healthcare Consulting (Accession), a specialist pharma market access consultancy, today announces that it has received private investment from a group of highly experienced healthcare and technology investors...

Out Of Office: The New Normal for Ad Agencies

White Papers and Resources | March 17, 2021 | Life Healthcare Communications

Covid has made working from home mandatory for most agencies. Life after lockdown may never be the same.

A Stellar Start to 2021 for Lucid Group

Press Releases | March 16, 2021 | Lucid Group Communications Limited

It’s been a stellar start to 2021 for Lucid Group, which has welcomed 38 new starters into the company since the beginning of the year. These include 15 Client Services...